Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mathew

Showing results (331-340 of 343) with videos related to

Pageof 35
Sort By:
Blood|May 21, 2005
Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functionsKyung-Mi Lee, John P Forman, Megan E McNerney, et al.
Clinical and Experimental Immunology|October 7, 2015
Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsE Townsley, G O'Connor, C Cosgrove, et al.
BMC Public Health|May 31, 2011
Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in IndiaRashmi Sinha, Carrie R Daniel, Niveditha Devasenapathy, et al.
Blood Advances|February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomasDai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2019
Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusA K Das, A Mithal, K M P Kumar, et al.
MMWR. Morbidity and Mortality Weekly Report|May 18, 2019
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019Lynn E Sosa, Gibril J Njie, Mark N Lobato, et al.
British Journal of Haematology|October 17, 2023
Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over timeS Boyle, C Roddie, M O'Reilly, et al.
Digestive Diseases and Sciences|May 17, 2020
Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot StudyM C Valenzano, E Rybakovsky, V Chen, et al.
Infection Control and Hospital Epidemiology|July 13, 2021
Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnelDavid J Weber, Jaffar A Al-Tawfiq, Hilary M Babcock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancerR J Hartmaier, S E Trabucco, N Priedigkeit, et al.
Pageof 35

Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
Blood|May 21, 2005
Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functionsKyung-Mi Lee, John P Forman, Megan E McNerney, et al.
Clinical and Experimental Immunology|October 7, 2015
Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsE Townsley, G O'Connor, C Cosgrove, et al.
BMC Public Health|May 31, 2011
Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in IndiaRashmi Sinha, Carrie R Daniel, Niveditha Devasenapathy, et al.
Blood Advances|February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomasDai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2019
Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusA K Das, A Mithal, K M P Kumar, et al.
MMWR. Morbidity and Mortality Weekly Report|May 18, 2019
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019Lynn E Sosa, Gibril J Njie, Mark N Lobato, et al.
British Journal of Haematology|October 17, 2023
Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over timeS Boyle, C Roddie, M O'Reilly, et al.
Digestive Diseases and Sciences|May 17, 2020
Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot StudyM C Valenzano, E Rybakovsky, V Chen, et al.
Infection Control and Hospital Epidemiology|July 13, 2021
Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnelDavid J Weber, Jaffar A Al-Tawfiq, Hilary M Babcock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancerR J Hartmaier, S E Trabucco, N Priedigkeit, et al.
Pageof 35